Oxymorphone Extended-Release Tablets and Sodium Phenylbutyrate Powder
Determining the interaction of Oxymorphone Extended-Release Tablets and Sodium Phenylbutyrate Powder and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxymorphone Extended-Release Tablets-Sodium Phenylbutyrate Tablets
- Oxymorphone Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic
- Oxymorphone Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Oxymorphone Extended-Release Tablets-Sodium phosphate p 32 Intravenous
- Oxymorphone Extended-Release Tablets-Sodium Phosphates
- Oxymorphone Extended-Release Tablets-Sodium Phosphates Enema
- Sodium Phenylbutyrate Powder-Oxymorphone Hydrochloride
- Sodium Phenylbutyrate Powder-Oxymorphone Injection
- Sodium Phenylbutyrate Powder-Oxymorphone Tablets
- Sodium Phenylbutyrate Powder-Oxytocin
- Sodium Phenylbutyrate Powder-Oxytocin Intravenous, Intramuscular
- Sodium Phenylbutyrate Powder-Oxytrol